Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
HSA · 6 medicines
Anvisa · 4 medicines
AEMPS · 4 medicines
SFDA · 4 medicines · Historical list
HALMED · 2 medicines
AIFA · 2 medicines
PHARMAC · 2 medicines
FDA · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
42 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Acitretin | United States | 10MG, 17.5MG, 22.5MG … | capsule | Marketed | Barr Labs INC |
| Acitretina | Brazil | Authorised | Glenmark Farmacêutica Ltda | ||
| Acitretine CF 10 mg, capsules | Netherlands | Capsule, hard | Authorised | Centrafarm B.V. | |
| Acitretine CF 25 mg, capsules | Netherlands | Capsule, hard | Authorised | Centrafarm B.V. | |
| Acitretine IFC 10 mg, capsules | Netherlands | Capsule, hard | Authorised | Industrial Farmaceutica Cantabria S.A. | |
| Acitretine IFC 25 mg, capsules | Netherlands | Capsule, hard | Authorised | Industrial Farmaceutica Cantabria S.A. | |
| ACITRETINA IFC 10 mg CAPSULAS DURAS EFG | Spain | 10 mg | cápsula dura | Marketed | Industrial Farmaceutica Cantabria S.A. |
| ACITRETINA IFC 25 mg CAPSULAS DURAS EFG | Spain | 25 mg | cápsula dura | Marketed | Industrial Farmaceutica Cantabria S.A. |
| Mint-Acitretin | Canada | 10 MG | Capsule | Marketed | Mint Pharmaceuticals INC |
| Mint-Acitretin | Canada | 25 MG | Capsule | Marketed | Mint Pharmaceuticals INC |
| Taro-Acitretin | Canada | 25 MG | Capsule | Marketed | Taro Pharmaceuticals INC |
| Taro-Acitretin | Canada | 10 MG | Capsule | Marketed | Taro Pharmaceuticals INC |
| Jamp Acitretin | Canada | 10 MG | Capsule | Authorised | Jamp Pharma Corporation |
| Jamp Acitretin | Canada | 25 MG | Capsule | Authorised | Jamp Pharma Corporation |
| Soriatane | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | capsule | Not marketed | Stiefel Labs INC |
| Acitret Capsule 10MG | Singapore | 10.00mg | capsule | Authorised | Goldplus Universal Pte LTD |
| Acitret Capsule 25MG | Singapore | 25.00mg | capsule | Authorised | Goldplus Universal Pte LTD |
| Novatretin | New Zealand | Cap 25 mg | Funded | ||
| Novatretin | New Zealand | Cap 10 mg | Funded | ||
| Novatretin Capsule 10MG | Singapore | 10.0mg | capsule | Authorised | Apex Pharma Marketing Pte. LTD. |
| Novatretin Capsule 25MG | Singapore | 25.0mg | capsule | Authorised | Apex Pharma Marketing Pte. LTD. |
| Neotigason 10 MG Capsulas Duras | Spain | 10 mg | cápsula dura | Marketed | Aurovitas Spain, S.A.U. |
| Neotigason 25 MG Capsulas Duras | Spain | 25 mg | cápsula dura | Marketed | Aurovitas Spain, S.A.U. |
| Neotigason | Italy | Capsula rigida | Authorised | Aurobindo Pharma (Italia) S.R.L. | |
| Neotigason 10 mg, capsules | Netherlands | Capsule, hard | Authorised | Aurobindo Pharma B.V. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
